Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Sankyo Co., Ltd. engages in the manufacture and sale of pachinko and pachislot machines. It operates through the following segments: Pachinko Machines Business, Pachislot Machines Business, Ball Bearing Supply Systems Business, and Others. The Pachinko Machines Business segment produces and sells pachinko machines, machine gauges and its related parts. The Pachislot Machines Business segment markets pachislot machines and related parts. The Ball Bearing Supply Systems segment sells pachinko and pachislot ball feeders, card system equipment, and parlor-related equipment. The Others segment comprises of mobile content service, real estate, golf club operations, and sells general molding products. The company was established on April 12, 1966 and is headquartered in Tokyo, Japan.

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

Sequenom (NASDAQ: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, and the SensiGene RHD Fetal RHD genotyping test.

The Texas A&M University System creates a seamless pathway for students to earn an associate and bachelor’s degree in related fields

Ayers (Zhejiang) Medical Technology Co., Ltd., established on 2016-10-27, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;glassware manufacturing;Glassware Sales;Technology development of biological reagents,technology transfer,technical consulting,Technical Services(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Research and development of glass instruments;Research and Development of Experimental Instruments,manufacture,Sales.(The branch office is located in:Asia Pacific Road, Nanhu District, Jiaxing City, Zhejiang Province906Chinese Academy of Sciences Phase III15building)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Guangzhou Jingke Biotechnology Co., Ltd., established on 2015-08-12, Business scope includes biotechnology extension services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Operation of non-licensed medical devices(i.e. no application required<Medical device operating enterprise license>ready-to-operate medical device",Including Class I medical devices and national regulations do not require application<Medical device operating enterprise license>Ready-to-operate Class II Medical Devices);Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);Licensed medical device business(apply<Medical device operating enterprise license>medical device",Including the third class of medical devices and need to apply<Medical device operating enterprise license>Class II medical devices that can only be operated);

Chengdu Nord Medical Laboratory Co., Ltd., established on 2021-03-23, Business scope includes licensed projects:medical service;Inspection and testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Health Consulting Services(Does not include medical services);Experimental analysis instrument sales;Biochemical product technology research and development;Wholesale of protective equipment for medical staff;Retailing of protective equipment for healthcare workers;Natural science research and experimental development;Sales of Class I Medical Devices;Sales of hygiene products and single-use medical products;Specialty Chemicals Sales(Free of Hazardous Chemicals);Pharmaceutical special equipment sales;software development;Artificial intelligence application software development;internet data service;IoT application service;Network and Information Security Software Development;Artificial intelligence theory and algorithm software development;Artificial intelligence basic software development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Oncolys BioPharma Inc. is a biopharmaceutical company. The Company operates in two business segments. Pharmaceutical business segment is engaged in the research, development, manufacture and marketing of pharmaceuticals. Diagnostic reagents business segment is engaged in the research, development, manufacture and marketing of diagnostic reagents and equipment, as well as the provision of inspection service. The Company's main pipeline includes OBP-601 for the treatment of human immunodeficiency virus (HIV) infection; OBP-301 (Telomelysin), an oncolytic virus; OBP-801, an epigenetic anticancer drug; OBP-1101 (Telomescan F35), a virus for blood floating cancer cells (CTC) detection; OBP-401 (Telomescan), a virus for inflammatory disease detection, and OBP-1102, a virus for leukemia detection, among others.

Union Stem Cell & Gene Engineering Co., Ltd. engages in the development of stem cell therapeutic products. Its business activities include stem cell resource conservation, stem cell clinical transplant, and research and development of monoclonal antibodies treatment and gene chip. The company was founded on February 16, 2001 and is headquartered in Tianjin, China.

Shenzhen Huayuan Regenerative Medicine Co., Ltd., established on 2018-05-07, Business scope includes general business items:Regenerative Medicine Technology Development,technology transfer,technical consulting;biotechnology development,Biotechnology Consulting,biotechnology transfer;Operating import and export business;biotechnology development,Biomedical Technology Research:General machinery and equipment retail;Mechanical equipment technology development;Mechanical equipment technical consultation;Stem cell technology research and development;Provide computer information technology support management by undertaking service outsourcing,Data Processing Information Technology Services,Computer software and hardware development.,The licensing program is:Biological Products SalesIIkindIIIkind6846Production of implant materials and artificial organs,Sales;Medical supplies and equipment retail(Does not contain drugs and medical devices);Manufacture of educational models and teaching aids;Manufacturing of special equipment for teaching;Testing machine manufacturing;Special machinery manufacturing with independent functions;Manufacture of other synthetic materials(Monitor Chemicals,Excluding hazardous chemicals),Man-made superhard material manufacturing.

Shandong Meiyi Biotechnology Co., Ltd., established on 2020-09-16, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Instrument Repair;Instrument sales;Machinery sales;electronic,Mechanical equipment maintenance(No special equipment);electronics sales;Retailing of computer software, hardware and auxiliary equipment;Computer and Office Equipment Repair;Sales of plastic products;Network technology service;Economic and Trade Consulting;Information Consulting Service(Not including licensing information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Chengdu Aiweifu Biotechnology Co., Ltd., established on 2017-01-25, Business scope includes biotechnology development,technical consulting,Technical Services,technology transfer;software development;Instrumentation,chemical reagent,Polymer Materials,Research and development of active equipment and consumables,Production,Sales;Medical device research and development.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).Medical device production,Sales.(Did not obtain the relevant administrative license(approval),Do not carry out business activities).

Guangdong Messer Cell Biotechnology Co., Ltd., established on 2017-12-19, Business scope includes services:Biological product,Research and development of biomaterials and bioscience technologies,Technical consultation and exchange,Technology promotion and technology transfer services,Stem cell technology research and development,Medical Research and Experimental Development,Storage and Preparation of Stem Cells,Stem Cell Collection and Storage Services(Without umbilical cord blood hematopoietic stem cell collection,storage),Immune cell storage and preparation,Immune cell collection and storage service(Without umbilical cord blood hematopoietic stem cell collection,storage),Stem Cell Drug Technology Research,Food Science and Technology Research,Enterprise Management Services(Excluding investment and asset management),Business Management Consulting;Sales:cosmetic,hygiene products,medical supplies,First,Class II medical device;retail:department store;Production:cosmetic,First,Class II medical device,non-medical masks;Domestic Trade;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

China Tobacco Yunnan Industrial Co. Ltd. is a company headquartered in China ultimately controlled by the Government of China. The firm manufactures tobacco products.

Beijing Selfusen Biotechnology Co., Ltd., established on 2011-12-05, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services,Technical Training;Sales of chemical products(Does not contain dangerous chemicals and a class of precursor chemicals),medical instruments(limitIkind),Instrumentation.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Beijing Shengpu Boda Biotechnology Co., Ltd., established on 2012-12-25, Business scope includes technical promotion services;Technology Import and Export;Agent import and export;Import and export;Application software service(Does not contain medical software);computer graphic design,make;Sales of medical devicesIkind,Class II Medical Devices,daily necessities,cosmetic,crafts,Equipment,electronic product,household appliances,Stationery,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),automobile parts,car decoration,lubricating oil,grease,Disinfectant;packaging service;Sales of Class III Medical Devices;sell food.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III Medical Devices,Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Tianjin Zhongyi Anjian Biotechnology Co., Ltd., established on 2020-07-13, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).